wire - news in brief

« BACK

Pharmacology



Results 1 - 32 of 32.


Health - Pharmacology - 10.10.2024
New KU Leuven spin-off fosters therapeutic treatment in everyday life
With the help of a science-based smartphone app, psychotherapists and psychologists can now enhance their patients' treatment with interventions and assessments in everyday life.

Health - Pharmacology - 04.06.2024
A Belgian-led consortium ’making antibiotics great again’ with phage* therapy
The Belgian-led consortium consisting of groups from The Queen Astrid Military Hospital (QAMH), KU Leuven and the public health institute Sciensano recently made the cover of Nature Microbiology.

Health - Pharmacology - 02.05.2024
KU Leuven Secures $2.8 Million Grant to Investigate Origins of Crohn’s Disease Fibrosis
Crohn's disease, affecting approximately 2 million people around the world, manifests with intestinal inflammation and abdominal pain.

Health - Pharmacology - 01.02.2024
VUB to lead international consortium on palliative care for chronic lung disease

Health - Pharmacology - 17.01.2024
GLIOMATCH: Pioneering hope for malignant glioma, a deadly brain cancer
The World Health Organization reveals a sombre reality: cancer ranks as the world's second-leading cause of death.

Health - Pharmacology - 13.12.2023
An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart

Health - Pharmacology - 04.12.2023
Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral candidate Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.  
Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology (IVTD) lab at the Vrije Universiteit Brussel, and doctoral candidate Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.  

Pharmacology - Environment - 01.12.2023
VUB launches new alcohol and drugs policy

Pharmacology - Health - 24.10.2023
KU Leuven research into the treatment of endometriosis receives substantial Danish support
KU Leuven and the Danish BioInnovation Institute (BII) will jointly look for new therapeutic drugs for the gynecological disorder endometriosis over the next three years.

Health - Pharmacology - 19.10.2023
The Centre for Drug Design and Discovery raises 70.5 Million Euros for its fourth fund

Pharmacology - Chemistry - 22.08.2023
VUB chemist mimics natural protein to accelerate drug development
VUB chemist mimics natural protein to accelerate drug development
Professor Steven Ballet, head of the Organic Chemistry research group at the Vrije Universiteit Brussel, has received the international Evotec Award for Excellence in Molecular Design from the French Société de Chimie Thérapeutique.

Pharmacology - Health - 14.07.2023
VUB neurologist argues for affordability of new Alzheimer’s drug

Health - Pharmacology - 27.04.2023
Clinnova to Launch Precision Medicine Initiative Across Europe
Inaugurating a new initiative to foster AI-driven precision medicine via data federation, standardisation, and interoperability.

Pharmacology - Life Sciences - 25.04.2022
EU funding for the development of technology towards a personalized treatment for depression
EU funding for the development of technology towards a personalized treatment for depression

Pharmacology - Health - 17.03.2022
Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals

Health - Pharmacology - 09.02.2022
VUB Hematology and UZ Brussel win prizes
The Hematology-Immunology research group at VUB and the Hematology department UZ Brussel have received three awards for their research into better treatment of blood cancer.

Health - Pharmacology - 03.02.2022
Better communication should lead to more appropriate care for young cancer patients
"The goal is to improve communication between young cancer patients (between 10 and 18 years old), their parents and the medical staff, and thereby also optimise care," says Anne van Driessche, third

Health - Pharmacology - 03.02.2022
Researchers study partial failure of immunotherapy
The teams of VUB professors Bart Neyns, Sandra Tuyaerts and Karine Breckpot will join research groups from UCL, Bordet Institute and ULB in their search for factors that explain why current immunotherapies fail in all patients.

Health - Pharmacology - 01.02.2022
Helping cancer patients fulfil their desire to have children
Professors Michel De Vos and Ellen Anckaert work at UZ Brussel and are affiliated with VUB.

Health - Pharmacology - 31.01.2022
Researchers and start-up Esobiotec pursue affordable cancer immunotherapy

Pharmacology - Campus - 22.09.2021
VUB opens vaccination centre on campus in Etterbeek

Health - Pharmacology - 26.07.2021
Majority favour Covid vaccination
Flemish are more positive about vaccine than Walloons; half of non-vaccinated people do not want to be vaccinated The Vrije Universiteit Brussel and VUB spin-off iCense conducted a survey among Belgians to find out people's reasons for choosing to be vaccinated against Covid-19 or not.

Health - Pharmacology - 23.06.2021
ETheRNA and VUB expand strategic collaboration to engineer next generation mRNA therapeutics with TetraMix
Extension to proven TriMix adjuvant technology intended to boost dendritic cell activation eTheRNA immunotherapies NV ('eTheRNA', Niel, Belgium ), a clinical-stage company developing mRNA-based immun

Health - Pharmacology - 26.01.2021
Belgian initiative for AI lung scan analysis in fight against COVID-19 goes European
Icovid is being rolled out across Europe and is on the OECD shortlist for AI initiatives against current and future pandemics The Belgian initiative icovid, which supports radiologists in the assessm

Pharmacology - 10.05.2020
Belgium invests in contained facility and laboratories for testing vaccines

Pharmacology - 23.12.2019
Launch of VAXVOX

Pharmacology - Health - 16.12.2019
KU Leuven and VIB announce new spin-off Augustine Therapeutics to fight neuromuscular diseases

Pharmacology - Health - 01.12.2019
CRIG-researchers are granted 5 million euro by 'Kom op tegen Kanker' 2019
CRIG-researchers are granted 5 million euro by ’Kom op tegen Kanker’ 2019

Social Sciences - Pharmacology - 18.11.2019
Ghent University strengthens ties with ten top universities in China and signs six cooperation agreements
Ghent University strengthens ties with ten top universities in China and signs six cooperation agreements

Pharmacology - 04.09.2019
HZI coordinates the development of a nasal vaccination against Chagas disease

Health - Pharmacology - 01.04.2019
UAntwerp and partners fight against antibiotic resistance

Health - Pharmacology - 06.12.2018
Half a million for cardiovascular anomalies research
The first Generet Award, which was launched this year, has gone to Professor Miikka Vikkula (de Duve Institute - UCLouvain) for his research seeking a genetic explanation for vascular anomalies.